Recombinant Treponema denticola Ribonuclease Z (rnz)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and serves as a guideline.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is finalized during production. If you require a specific tag, please inform us for preferential development.
Synonyms
rnz; TDE_1951; Ribonuclease Z; RNase Z; EC 3.1.26.11; tRNA 3 endonuclease; tRNase Z
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-308
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Treponema denticola (strain ATCC 35405 / CIP 103919 / DSM 14222)
Target Names
rnz
Target Protein Sequence
MNLEAFILGC GGMMPLPYRH LTSVLLRREG DLFLFDCGEG TQVALRRLNL RWKRINAIFI SHTHADHITG LPGLLMLSSQ VDREEPLYII GPPKVAEYVE TSRKVLDMYI NYEIIVKEIR EPGVVYSTEE FQVRSFWLDH TKPCMGYTFE EFERPGEFNP EAARALNVPC GPLWSKLQGG NEVVSADGKT IRPQDVMGPK RKGRKFSFVT DTKYLPSIAQ EVKYSDFFVC EGMFEKGMEK DAAEKKHMTC TQAAQIAKDA EVKKMALIHY SPRYTDNELK VLLDHAREVF PETILSKDRM NIQLEYED
Uniprot No.

Target Background

Function

Zinc phosphodiesterase exhibiting tRNA 3'-processing endonuclease activity. It likely participates in tRNA maturation by removing 3'-trailer sequences from precursor tRNA.

Database Links

KEGG: tde:TDE1951

STRING: 243275.TDE1951

Protein Families
RNase Z family

Q&A

What is the genomic context of Ribonuclease Z in Treponema denticola?

Ribonuclease Z (rnz) in T. denticola is part of the organism's RNA processing machinery. While the search results don't specifically identify the rnz gene locus, transcriptome profiling has revealed that RNA processing genes in T. denticola show differential expression between laboratory culture and in vivo conditions within periodontal pockets . This indicates that rnz expression may be context-dependent, potentially influenced by the complex microbial community and host factors present in periodontal disease environments. To properly study this enzyme, researchers should consider both its genomic location and regulatory elements that may influence its expression under different environmental conditions.

Which expression systems are most suitable for producing recombinant T. denticola rnz?

For recombinant expression of T. denticola proteins, several systems can be considered based on the characteristics of the target protein. For cytoplasmic proteins like rnz, E. coli expression systems coupled with T. denticola shuttle plasmids offer promising results. The search results indicate that shuttle plasmids derived from pKMR4PE, which is based on the pTS1 plasmid originally found in oral Treponema clinical isolates, have been successfully used for gene expression in T. denticola . When expressing T. denticola proteins in heterologous systems, it's important to consider potential toxicity issues, as noted with certain T. denticola outer membrane proteins whose overexpression is problematic in both E. coli and T. denticola .

How do promoter choices affect the expression levels of recombinant rnz?

Promoter selection significantly impacts recombinant protein expression levels in T. denticola. The search results demonstrate that different promoters exhibit varying strength in driving gene expression. For example, transcription levels driven by the msp promoter (P-msp) were approximately 7-fold higher than those driven by the tap1 promoter (P-tap1) when normalized to plasmid copy number . For rnz expression, selecting an appropriate promoter depends on the desired protein levels and potential toxicity. If rnz overexpression might be detrimental to cell viability, using a relatively weak promoter like P-tap1 could be advantageous. Conversely, if high expression is required, the stronger P-msp promoter might be preferred, provided that rnz overexpression is well-tolerated.

What purification strategies are effective for recombinant T. denticola proteins?

While the search results don't specifically address purification of rnz, they describe approaches used for other T. denticola proteins that could be adapted. For envelope-associated proteins like TmpC and Msp, fractionation protocols have been established to isolate these components . For cytoplasmic enzymes like rnz, standard affinity purification methods using tags such as His-tag or GST-tag would likely be effective. The choice of purification strategy should consider the protein's cellular localization, solubility, and tendency to form aggregates. For rnz specifically, RNA binding capacity should also be considered when selecting purification conditions to prevent non-specific RNA interactions during purification.

How does rnz expression in T. denticola vary between laboratory culture and periodontal disease environments?

Transcriptome analysis has revealed substantial differences in gene expression profiles between T. denticola grown in laboratory culture versus in periodontal pockets . While the search results don't specifically mention rnz, they indicate that 257 genes were up-regulated and 730 genes were down-regulated in periodontal pockets compared to laboratory conditions . RNA processing enzymes like rnz may show environment-specific expression patterns, possibly responding to changes in nutrient availability, oxidative stress, or interactions with host cells and other microorganisms. To accurately assess rnz expression in disease-relevant contexts, researchers should compare transcriptome data from multiple patient samples and laboratory cultures, considering both log and stationary growth phases.

What role might rnz play in T. denticola virulence and host immune evasion?

T. denticola employs sophisticated mechanisms to evade host immune responses, as evidenced by virulence factors like T-Mac . While rnz's specific role in virulence is not directly addressed in the search results, RNA-processing enzymes could potentially contribute to pathogenicity by regulating the expression of virulence factors or modulating bacterial responses to host defenses. Recent research has identified novel virulence factors in T. denticola that are processed into functional units with distinct activities . Investigating whether rnz influences the expression or processing of such virulence factors could provide insights into its potential role in pathogenesis.

Can T. denticola rnz be targeted for antimicrobial drug development?

Ribonucleases are potential targets for antimicrobial development due to their essential role in RNA processing. While the search results don't directly address this question for rnz, they provide insights into T. denticola biology that could inform drug development strategies. For example, understanding the structure and catalytic mechanism of rnz could guide the design of specific inhibitors. The search results mention that some T. denticola proteins, like the C-terminal fragment of T-Mac, have unique structures and activities . If rnz exhibits T. denticola-specific structural or functional features, these could potentially be exploited for selective targeting.

What are the optimal conditions for expressing recombinant T. denticola rnz in E. coli?

Based on the search results, expressing T. denticola proteins in E. coli requires careful optimization. For cytoplasmic proteins like rnz, considerations include codon optimization, induction conditions, and potential toxicity issues. The search results note that "overexpression is problematic" for some T. denticola proteins in E. coli . To optimize rnz expression, researchers should consider:

ParameterRecommendationRationale
E. coli strainBL21(DE3), Rosetta(DE3), or similarEnhanced expression of proteins with rare codons
Expression vectorpET system with tunable promoterControl over expression levels to minimize toxicity
Induction0.1-0.5 mM IPTG, 16-20°C overnightSlower expression may enhance proper folding
Media supplements2% glucose for tighter controlPrevents leaky expression if rnz is toxic
Solubility tagsMBP or SUMO fusionEnhances solubility of potentially insoluble proteins

These recommendations are based on general practices for expressing challenging proteins and should be optimized specifically for rnz.

How can researchers construct and validate T. denticola rnz mutants?

The search results describe methods for constructing gene-deletion mutants in T. denticola that could be adapted for rnz studies . A general workflow based on these methods would include:

  • Design a deletion cassette using PCR-based overlap extension, containing:

    • ~500 bp upstream region of rnz

    • Selectable marker (e.g., ermB for erythromycin resistance)

    • ~500 bp downstream region of rnz

  • Clone the cassette into a suitable vector (e.g., pGEM-T Easy) and verify by sequencing

  • Linearize the construct and electroporate into T. denticola (50 μg of DNA is recommended)

  • Select transformants on media containing appropriate antibiotics (e.g., 40 μg/ml erythromycin)

  • Confirm gene deletion by PCR and validate the phenotype through functional assays specific to rnz activity

For point mutations rather than complete gene deletions, site-directed mutagenesis could be employed to introduce specific changes to the rnz catalytic site.

What approaches can be used to study rnz enzyme kinetics and substrate specificity?

Ribonuclease Z typically cleaves the 3' trailer sequences from tRNA precursors. To study T. denticola rnz activity, researchers could:

  • Express and purify recombinant rnz with appropriate affinity tags

  • Generate synthetic tRNA precursor substrates with fluorescent labels

  • Perform cleavage assays under varying conditions to determine:

    • Optimal pH and temperature

    • Metal ion requirements (typically Mg²⁺ or Mn²⁺)

    • Kinetic parameters (Km, kcat, Vmax)

    • Substrate specificity among different tRNA precursors

A comparative approach examining rnz activity across different oral pathogens could provide insights into species-specific features of this enzyme.

How can transcriptome analysis inform the study of rnz function in T. denticola?

The search results describe transcriptome profiling of T. denticola in different environments . Similar approaches could be valuable for understanding rnz function:

  • Compare transcriptome profiles between wild-type and rnz-mutant T. denticola to identify affected genes

  • Examine tRNA processing and maturation in the presence and absence of functional rnz

  • Assess changes in gene expression under different environmental conditions that might influence rnz activity

Analysis TypeTechnical ApproachExpected Insights
RNA-SeqNext-generation sequencingGlobal transcriptome changes in rnz mutants
Northern blottingGel electrophoresis and probingSpecific tRNA processing defects
qRT-PCRTargeted amplificationValidation of expression changes in key genes
tRNA-SeqSpecialized small RNA sequencingDetailed analysis of tRNA processing intermediates

How can researchers address protein insolubility when expressing recombinant T. denticola rnz?

Protein insolubility is a common challenge when expressing heterologous proteins. The search results indicate that overexpression of certain T. denticola proteins can be problematic . If rnz shows poor solubility, consider:

  • Lowering expression temperature (16-20°C) to slow folding

  • Using solubility-enhancing fusion partners (MBP, SUMO, thioredoxin)

  • Optimizing buffers with stabilizing additives (glycerol, arginine, specific salts)

  • Expressing truncated domains if full-length protein is consistently insoluble

  • Experimenting with different expression hosts (e.g., Bacillus, yeast systems)

If the protein remains insoluble, purification under denaturing conditions followed by refolding might be necessary.

What strategies can overcome challenges in maintaining stable T. denticola shuttle plasmids?

The search results highlight challenges with plasmid stability in T. denticola. For example, when fhbB was expressed under the control of P-tap1 on a shuttle plasmid, "it could not be stably maintained, presumably due to overexpression of FhbB" . To improve plasmid stability when working with rnz:

  • Select an appropriate promoter with moderate strength to prevent toxic overexpression

  • Consider the plasmid copy number (the search results indicate approximately 2 copies per chromosome)

  • Ensure continuous selective pressure through appropriate antibiotic inclusion

  • Verify plasmid retention through regular PCR screening during experiments

  • For long-term studies, consider chromosomal integration as an alternative to plasmid-based expression

How can researchers differentiate between direct and indirect effects of rnz mutations?

  • Perform complementation studies to verify that phenotypes are specifically due to the rnz mutation

  • Develop catalytically inactive rnz mutants (by site-directed mutagenesis of key residues) to separate structural from enzymatic roles

  • Use inducible expression systems to control the timing and level of rnz expression

  • Compare phenotypes across multiple growth conditions to identify context-dependent effects

  • Combine genetic approaches with biochemical validation using purified components

How might rnz function relate to the adaptation of T. denticola to the periodontal pocket environment?

The search results indicate substantial differences in gene expression between laboratory and periodontal pocket environments, with 257 genes up-regulated and 730 down-regulated in vivo . Future research could explore whether rnz activity is modulated in response to environmental factors such as nutrient availability, pH, or host defense molecules. Understanding how rnz function contributes to T. denticola adaptation might provide insights into bacterial survival strategies in the periodontal pocket and potentially reveal new targets for therapeutic intervention.

Could rnz contribute to horizontal gene transfer and antibiotic resistance acquisition in T. denticola?

The search results mention that restriction modification systems and CRISPR-associated genes are down-regulated in the periodontal pocket environment . These systems typically protect against foreign DNA, so their down-regulation might facilitate horizontal gene transfer. Future research could investigate whether rnz plays any role in regulating these defense systems or in processing foreign RNA molecules acquired through horizontal transfer. This could potentially influence the acquisition of antibiotic resistance genes or virulence factors from other oral microbes.

What is the relationship between rnz activity and the expression of known virulence factors in T. denticola?

T. denticola expresses various virulence factors, including the major outer sheath protein (Msp), dentilisin, and T-Mac . Future research could explore whether rnz activity influences the expression or function of these virulence factors, potentially through effects on global RNA processing or specific regulatory pathways. This could provide a more comprehensive understanding of T. denticola pathogenesis and identify potential targets for disrupting virulence mechanisms.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.